Short Symptom Questionnaire (SSQ)
blurred vision, nausea, ®, fatigue, disorientation, headache
ADVERSE EFFECTS, INCREASED SALIVATION
This questionnaire was used to assess the possible manifestation of adverse effects resulting from the experimental treatment using the MYO Armband® sensor in the EG during the post-treatment evaluation. It includes three general dimensions: "nausea," "oculo-motor" symptoms and "disorientation." Participants were asked to rate the severity of each symptom on a five-point scale ("not at all," "mildly," "moderately," "definitely," and "severely") up to 45 min after immersion. Within these three dimensions, the SSQ includes symptoms such as fatigue, headache, blurred vision and increased salivation, among others. Higher scores indicated greater perception of adverse effects resulting from the experimental intervention. Although it has not yet been validated as an independent measure in Spanish, the SSQ provides a convenient profile of symptoms experienced with VR systems [